J AM ACAD DERMATOL - Journal of the American Academy of Dermatology
Publications
- 2022
Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial
Blauvelt, A., Langley, R. G., Lacour, J-P., Toth, D., Laquer, V., Beissert, S., Wollenberg, A., Herranz, P., Pink, A. E., Peris, K., Fangel, S., Gjerum, L., Corriveau, J., Saeki, H., Warren, R. B., Simpson, E. & Reich, K., 10.2022, In: J AM ACAD DERMATOL. 87, 4, p. 815-824 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2021
Immunoglobulin M pemphigoid
Boch, K., Hammers, C. M., Goletz, S., Kamaguchi, M., Ludwig, R. J., Schneider, S. W., Zillikens, D., Hadaschik, E. & Schmidt, E., 12.2021, In: J AM ACAD DERMATOL. 85, 6, p. 1486-1492 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis
Langley, R. G., Poulin, Y., Srivastava, B., Lafferty, K. P., Fakharzadeh, S., Langholff, W. & Augustin, M., 01.2021, In: J AM ACAD DERMATOL. 84, 1, p. 60-69 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2020
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis
Simpson, E., Bissonnette, R., Eichenfield, L. F., Guttman-Yassky, E., King, B., Silverberg, J. I., Beck, L. A., Bieber, T., Reich, K., Kabashima, K., Seyger, M., Siegfried, E., Stingl, G., Feldman, S. R., Menter, A., van de Kerkhof, P., Yosipovitch, G., Paul, C., Martel, P., Dubost-Brama, A., Armstrong, J., Chavda, R., Frey, S., Joubert, Y., Milutinovic, M., Parneix, A., Teixeira, H. D., Lin, C-Y., Sun, L., Klekotka, P., Nickoloff, B., Dutronc, Y., Mallbris, L., Janes, J. M., DeLozier, A. M., Nunes, F. P. & Paller, A. S., 09.2020, In: J AM ACAD DERMATOL. 83, 3, p. 839-846 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Integrated safety analysis: Frequency of urinary tract infections in patients with psoriasis treated with ixekizumab
Smith, S. D., Conrad, C., Ramharter, M., Gottlieb, A. B., Patel, H., Xu, W., Riedl, E. & Schuster, C., 07.2020, In: J AM ACAD DERMATOL. 83, 1, p. 261-263 3 p.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials
Reich, K., Griffiths, C. E. M., Gordon, K. B., Papp, K. A., Song, M., Randazzo, B., Li, S., Shen, Y-K., Han, C., Kimball, A. B., Armstrong, A. W., Foley, P. & Blauvelt, A., 04.2020, In: J AM ACAD DERMATOL. 82, 4, p. 936-945 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study
Deleuran, M., Thaçi, D., Beck, L. A., de Bruin-Weller, M., Blauvelt, A., Forman, S., Bissonnette, R., Reich, K., Soong, W., Hussain, I., Foley, P., Hide, M., Bouaziz, J-D., Gelfand, J. M., Sher, L., Schuttelaar, M. L. A., Wang, C., Chen, Z., Akinlade, B., Gadkari, A., Eckert, L., Davis, J. D., Rajadhyaksha, M., Staudinger, H., Graham, N. M. H., Pirozzi, G. & Ardeleanu, M., 02.2020, In: J AM ACAD DERMATOL. 82, 2, p. 377-388 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2018
Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial
Steinke, S., Zeidler, C., Riepe, C., Bruland, P., Soto-Rey, I., Storck, M., Augustin, M., Bobko, S., Garcovich, S., Legat, F. J., Lvov, A., Misery, L., Osada, N., Reich, A., Şavk, E., Serra-Baldrich, E., Streit, M., Szepietowski, J. C., Weger, W., Dugas, M. & Ständer, S., 09.2018, In: J AM ACAD DERMATOL. 79, 3, p. 457-463.e5Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: Results Through 48 Weeks of a Phase 3, Multicenter, Randomized, Double-Blinded, Etanercept- and Placebo-Controlled Study (CIMPACT)
Lebwohl, M., Blauvelt, A., Paul, C., Sofen, H., Węgłowska, J., Piguet, V., Burge, D., Rolleri, R., Drew, J., Peterson, L. & Augustin, M., 08.2018, In: J AM ACAD DERMATOL. 79, 2, p. 266-276.e5Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study
Puig, L., Augustin, M., Blauvelt, A., Gottlieb, A. B., Vender, R., Korman, N. J., Thaçi, D., Zhao, Y., Gilloteau, I., Sherif, B., Williams, N., Guana, A. & Lebwohl, M. G., 04.2018, In: J AM ACAD DERMATOL. 78, 4, p. 741-748 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2016
Tofacitinib Improves Pruritus and Health-Related Quality of Life up to 52 weeks: Results from 2 Randomized Phase III Trials in Patients With Moderate to Severe Plaque Psoriasis
Feldman, S. R., Thaçi, D., Gooderham, M., Augustin, M., de la Cruz, C., Mallbris, L., Buonanno, M., Tatulych, S., Kaur, M., Lan, S., Valdez, H. & Mamolo, C., 12.2016, In: J AM ACAD DERMATOL. 75, 6, p. 1162-1170Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2015
Ingenol mebutate gel for actinic keratosis: the link between quality of life, treatment satisfaction, and clinical outcomes
Augustin, M., Tu, J. H., Knudsen, K. M., Erntoft, S., Larsson, T. & Hanke, C. W., 05.2015, In: J AM ACAD DERMATOL. 72, 5, p. 816-821 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2011
Ovicidal efficacy of high concentration dimeticone: a new era of head lice treatment
Heukelbach, J., Sonnberg, S., Becher, H., Melo, I., Speare, R. & Oliveira, F. A., 01.04.2011, In: J AM ACAD DERMATOL. 64, 4, p. e61-2Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2010
The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial.
Menter, A., Augustin, M., Signorovitch, J., Yu, A. P., Wu, E. Q., Gupta, S. R., Bao, Y. & Mulani, P., 2010, In: J AM ACAD DERMATOL. 62, 5, p. 812-818 5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2004
Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma.
Coors, E. & von den Driesch, P., 2004, In: J AM ACAD DERMATOL. 50, 3, p. 363-367 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2002
Bilateral temporal arteritis.
Coors, E. & Simon, M., 2002, In: J AM ACAD DERMATOL. 46, 2, p. 14-15 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Localized cutaneous small to medium-sized pleomorphic T-cell lymphoma: a report of 3 cases stable for years.
von den Driesch, P. & Coors, E., 2002, In: J AM ACAD DERMATOL. 46, 4, p. 531-535 4.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review